Vaginal Electrical Stimulation, TTNS Both Effective for Overactive Bladder

Transcutaneous tibial nerve electrical stimulation provided residual effects over time, with higher proportion of patients reporting improvement in QoL one month posttreatment

toilet flush incontinence
Adobe Stock

FRIDAY, May 5, 2023 (HealthDay News) -- Short-term interventions of vaginal electrical stimulation (VS) and transcutaneous tibial nerve electrical stimulation (TTNS) are effective for treating overactive bladder syndrome (OAB) in women, according to a study published online April 12 in Neurourology & Urodynamics.

Janaina Mayer de Oliveira Nunes, from the State University of Londrina in Brazil, and colleagues randomly assigned 69 patients with OAB to receive 12 sessions of VS versus TTNS or no treatment (control group [CG]) over six weeks. At baseline, six weeks, and one month after treatment, OAB impact was evaluated according to the International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ‐OAB) module, symptoms discomfort scores, and voiding diaries.

The researchers observed significant reductions in ICIQ-OAB scores in association with both TTNS and VS (mean difference, −4.2 and −3.8, respectively), as well as reductions in discomfort sensation at six weeks compared with the CG (−3.9 and −2.8, respectively). One month after treatment, the ICIQ-OAB score remained low only in the TTNS group compared with the CG (−3.6). Compared with the CG, improvement in discomfort symptoms was seen in both active groups (−3.2 and −2.6 for TTNS and VS, respectively). Comparing TTNS and VS, there were no significant differences in the primary outcomes.

"TTNS and VS were both effective in improving quality of life and discomfort by using the same parametrization," the authors write. "However, the TTNS technique provided residual effects over time, showing a higher proportion of patients reporting substantial benefits in quality of life both at six weeks and one month posttreatment."

Abstract/Full Text

Elana Gotkine

Elana Gotkine

Medically reviewed by Mark Arredondo, M.D.

Published on May 05, 2023

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ